Patient StoriesHow We HelpResearch NewsSupport Our MissionSearch
Donate Now
Get Guidance
Donate Now
Get Guidance

Carla Grandori, MD, PhD

Founder and CEO of SEngine Precision Medicine
LinkedinX
Insights
PARIS Test Uses Lab-Grown Mini-Tumors to Find a Patient’s Best Treatment
The U.S. Food and Drug Administration (FDA) has approved hundreds of drugs for the treatment of cancer. However, some approved drugs are more effective for certain patients than others. Our curious Dr. George asks Carla Grandori, MD, PhD, Founder and CEO of SEngine Precision Medicine, about her company’s test to detect which drugs are likely to be most effective for a given patient’s solid tumor.
June 30, 2023
Expert Guidance
for Advanced Cancer
Patient Hotline +1 (877) 971 1200
Support Our Mission
Patient Stories
How We Help
Patient RegistrationCancer ResearchCCCS001 Study
Support Our Mission
DonationsAbout UsJoin Cancer CommonsFinancial Documents
Contact Us
Cancer Commons
2625 Middlefield Road Suite 104
Palo Alto, CA 94306
+1 650-289-4044
© 2026 Cancer Commons. Privacy Policy
FacebookYoutubeLinkedinX